Raymond J. Leveillee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Raymond J. Leveillee has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Scott M. Castle
Division of Endourology, Department of Urology, University of Miami, Miller School of Medicine, Miami, Florida
10 shared publicationsVladislav Gorbatiy
Division of Endourology, Department of Urology, University of Miami, Miller School of Medicine, Miami, Florida
9 shared publicationsNelson Salas
Department of Biomedical Engineering, University of Miami, Coral Gables, Florida
6 shared publicationsMichael A. Gorin
Division of Endourology, Laparoscopy, and Minimally Invasive Surgery, Department of Urology, University of Miami Miller School of Medicine, Miami, Florida
4 shared publicationsRajan Ramanathan
Joint Bioengineering and Endourology Developmental Surgical (JBEDS) Laboratory, Division of Endourology, Laparoscopy, and Minimally-Invasive Surgery, Department of Urology, University of Miami Miller School of Medicine, Miami, USA
3 shared publicationsCharles R. Moore
Division of Endourology, Department of Urology, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
2 shared publications
Latest Publications
- 1 April 2013
- Published by SAGE Publications in Journal of Endourology
- Vol. 27 (4) , 480-489
Oncologic Outcomes Using Real-Time Peripheral Thermometry-Guided Radiofrequency Ablation of Small Renal Masses
Background and Purpose: With the increased incidence of low-stage renal cancers, thermal ablation technology has emerged as a viable treatment option for extirpation in selected persons and is supported by the current American Urological Association guidelines. We present a 9-year, single institution experience with radiofrequency ablation (RFA) using real-time peripheral temperature monitoring of small renal masses focusing on oncologic outcomes. Patients and Methods: We reviewed our prospectively collected database of patients with renal masses who were treated between November 2001 and January 2011 with laparoscopic (LRFA) or CT-guided percutaneous RFA (CTRFA) with simultaneous real-time peripheral fiberoptic thermometry. Patients were followed radiographically at 1 month, 6 months, 1 year, and then annually. Clinicopathologic outcomes were collected and analyzed. Results: A total of 274 patients (211 male) aged 18 to 88 years (mean 67 years) with 292 renal tumors underwent LRFA (112) or CTRFA (180). Mean tumor size was 2.5 cm (0.7–5.3 cm). An intraoperative preablation biopsy showed 197 (67.4%) renal-cell carcinomas (RCC), and 77 (26.4%) benign tumors. Mean follow-up was 26 months (1–98 mos). The single ablation treatment radiographic success rate was 96% for all tumors and 94% for RCC. Metastatic RCC developed in one patient, who died. The Kaplan-Meier (KM) 3-year and 5-year cancer-specific survival was 100% and 98.6%, respectively. The KM 3-year and 5-year overall survival was 90.4% and 74.2%, respectively. Conclusion: RFA is a clinically effective and safe nephron-sparing treatment of patients with small renal masses. Our large cohort and intermediate-term experience adds to the building evidence for the efficacy of RFA for small renal cancers.
- 1 April 2013
- Published by SAGE Publications in Journal of Endourology
- Vol. 27 (4) , 480-489
Oncologic Outcomes Using Real-Time Peripheral Thermometry-Guided Radiofrequency Ablation of Small Renal Masses
Background and Purpose: With the increased incidence of low-stage renal cancers, thermal ablation technology has emerged as a viable treatment option for extirpation in selected persons and is supported by the current American Urological Association guidelines. We present a 9-year, single institution experience with radiofrequency ablation (RFA) using real-time peripheral temperature monitoring of small renal masses focusing on oncologic outcomes. Patients and Methods: We reviewed our prospectively collected database of patients with renal masses who were treated between November 2001 and January 2011 with laparoscopic (LRFA) or CT-guided percutaneous RFA (CTRFA) with simultaneous real-time peripheral fiberoptic thermometry. Patients were followed radiographically at 1 month, 6 months, 1 year, and then annually. Clinicopathologic outcomes were collected and analyzed. Results: A total of 274 patients (211 male) aged 18 to 88 years (mean 67 years) with 292 renal tumors underwent LRFA (112) or CTRFA (180). Mean tumor size was 2.5 cm (0.7–5.3 cm). An intraoperative preablation biopsy showed 197 (67.4%) renal-cell carcinomas (RCC), and 77 (26.4%) benign tumors. Mean follow-up was 26 months (1–98 mos). The single ablation treatment radiographic success rate was 96% for all tumors and 94% for RCC. Metastatic RCC developed in one patient, who died. The Kaplan-Meier (KM) 3-year and 5-year cancer-specific survival was 100% and 98.6%, respectively. The KM 3-year and 5-year overall survival was 90.4% and 74.2%, respectively. Conclusion: RFA is a clinically effective and safe nephron-sparing treatment of patients with small renal masses. Our large cohort and intermediate-term experience adds to the building evidence for the efficacy of RFA for small renal cancers.
- 1 June 2012
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 22 (5) , 492-495
Intravesical Methylene Blue Facilitates Precise Identification of the Diverticular Neck During Robot-Assisted Laparoscopic Bladder Diverticulectomy
Background: The aim of this report is to describe our surgical technique for robot-assisted laparoscopic bladder diverticulectomy. In this technique, methylene blue is instilled into the bladder to aid in intra-abdominal identification of the diverticular neck. Subjects and Methods: We retrospectively reviewed the records of patients who underwent robot-assisted bladder diverticulectomy by a single surgeon. Results: Between September 2008 and January 2011, 5 patients successfully underwent robot-assisted laparoscopic bladder diverticulectomy using 1% intravesical methylene blue. All cases were completed without intraoperative complication or need for open conversion. Mean operative time was 216 minutes, with a mean estimated blood loss of 45 mL. Patients were discharged 1–2 days following surgery. No patient experienced a perioperative complication. Conclusions: The robot-assisted approach for bladder diverticulectomy is a viable alternative to both open and laparoscopic surgery. The use of intravesical methylene blue greatly aids in identification of the diverticular neck during this procedure.
- 1 June 2012
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 22 (5) , 492-495
Intravesical Methylene Blue Facilitates Precise Identification of the Diverticular Neck During Robot-Assisted Laparoscopic Bladder Diverticulectomy
Background: The aim of this report is to describe our surgical technique for robot-assisted laparoscopic bladder diverticulectomy. In this technique, methylene blue is instilled into the bladder to aid in intra-abdominal identification of the diverticular neck. Subjects and Methods: We retrospectively reviewed the records of patients who underwent robot-assisted bladder diverticulectomy by a single surgeon. Results: Between September 2008 and January 2011, 5 patients successfully underwent robot-assisted laparoscopic bladder diverticulectomy using 1% intravesical methylene blue. All cases were completed without intraoperative complication or need for open conversion. Mean operative time was 216 minutes, with a mean estimated blood loss of 45 mL. Patients were discharged 1–2 days following surgery. No patient experienced a perioperative complication. Conclusions: The robot-assisted approach for bladder diverticulectomy is a viable alternative to both open and laparoscopic surgery. The use of intravesical methylene blue greatly aids in identification of the diverticular neck during this procedure.
- 15 January 2012
- Published by Springer Nature in World Journal of Urology
- Vol. 31 (5) , 1105-1110
Preoperative patient counseling for diagnostic renal biopsy and complications with renal radiofrequency ablation
- 15 January 2012
- Published by Springer Nature in World Journal of Urology
- Vol. 31 (5) , 1105-1110
Preoperative patient counseling for diagnostic renal biopsy and complications with renal radiofrequency ablation
- Open Access
- 1 January 2012
- Published by The Society of Laparoscopic and Robotic Surgeons in JSLS : Journal of the Society of Laparoscopic & Robotic Surgeons
- Vol. 16 (1) , 159-162
Salvage Robot-Assisted Partial Nephrectomy for the Management of Renal Cell Carcinoma Following Failed Stereotactic Radiotherapy
Nephron-sparing surgery is currently the standard of care for the management of small renal masses. While both neoadjuvant and adjuvant conventional external beam radiotherapy have failed to demonstrate an oncologic benefit for the treatment of renal cell carcinoma, more recent work aims to explore the utility of stereotactic radiotherapy. We present the case of a 70-year-old woman who failed primary treatment of a small renal mass with the CyberKnife radiotherapy system and describe her successful salvage treatment with robot-assisted partial nephrectomy. This case demonstrates the safety of robotic surgery for the management of renal tumors following failed stereotactic radiotherapy.
- 1 January 2012
- Published by The Society of Laparoscopic and Robotic Surgeons in JSLS : Journal of the Society of Laparoscopic & Robotic Surgeons
- Vol. 16 (1) , 159-162
Open AccessSalvage Robot-Assisted Partial Nephrectomy for the Management of Renal Cell Carcinoma Following Failed Stereotactic Radiotherapy
Nephron-sparing surgery is currently the standard of care for the management of small renal masses. While both neoadjuvant and adjuvant conventional external beam radiotherapy have failed to demonstrate an oncologic benefit for the treatment of renal cell carcinoma, more recent work aims to explore the utility of stereotactic radiotherapy. We present the case of a 70-year-old woman who failed primary treatment of a small renal mass with the CyberKnife radiotherapy system and describe her successful salvage treatment with robot-assisted partial nephrectomy. This case demonstrates the safety of robotic surgery for the management of renal tumors following failed stereotactic radiotherapy.
- 16 December 2011
- Published by Wiley in BJU International
- Vol. 109 (3) , 384-387
Radiofrequency ablation (RFA) therapy for renal angiomyolipoma (AML): an alternative to angio‐embolization and nephron‐sparing surgery
Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? The natural history of renal angiomyolipomas (AML) shows increasing size and increasing risk of haemorrhage. For those patients undergoing treatment, extirpative surgery or renal angio‐embolization has increased morbidity. Due to its haemostatic effect, radio‐frequency ablation (RFA) may be used safely and effectively for the treatment of small (<4 cm), symptomatic renal AML. This study represents the largest case series reporting on RFA for renal AML. OBJECTIVES: • To show that radiofrequency ablation (RFA) is safe and effective treatment for renal angiomyolipoma (AML). • Current treatments to reduce the risk of haemorrhage include tumour extirpation, angio‐embolization, or ablative therapy. PATIENTS AND METHODS: • Review of our prospective database revealed 15 patients with intraoperative biopsy confirmed renal AML undergoing RFA from February 2002 to March 2010. • Patients underwent either laparoscopic or computed tomography (CT)‐guided percutaneous RFA using either the Cool‐tip™ (Covidien, Inc. Boulder, CO, USA) or RITA™ (Angiodynamics®, Latham, NY, USA) RFA probe. • CT at 1 month, 6 months, 1 year, and annually thereafter. RESULTS: • In all, two male and 13 female patients with seven left‐sided and eight right‐sided tumours with a mean (range) size of 2.6 (1.0–3.7) cm underwent laparoscopic (five) or CT‐guided (10) RFA. • No intraoperative complications occurred. Minor complications included transient haematuria and intercostals nerve transection. Surgical complications included pneumonia and myocardial infarction. • There was no radiographic evidence of persistent AML (CT enhancement) at a mean follow‐up of 21 months. CONCLUSIONS: • The haemostatic effect of RFA allows renal lesions suspicious for AML to be treated without bleeding complications. • Avoids surgical risk of extirpation or embolization. • RFA for renal AML is safe and effective.
- 16 December 2011
- Published by Wiley in BJU International
- Vol. 109 (3) , 384-387
Radiofrequency ablation (RFA) therapy for renal angiomyolipoma (AML): an alternative to angio‐embolization and nephron‐sparing surgery
Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? The natural history of renal angiomyolipomas (AML) shows increasing size and increasing risk of haemorrhage. For those patients undergoing treatment, extirpative surgery or renal angio‐embolization has increased morbidity. Due to its haemostatic effect, radio‐frequency ablation (RFA) may be used safely and effectively for the treatment of small (<4 cm), symptomatic renal AML. This study represents the largest case series reporting on RFA for renal AML. OBJECTIVES: • To show that radiofrequency ablation (RFA) is safe and effective treatment for renal angiomyolipoma (AML). • Current treatments to reduce the risk of haemorrhage include tumour extirpation, angio‐embolization, or ablative therapy. PATIENTS AND METHODS: • Review of our prospective database revealed 15 patients with intraoperative biopsy confirmed renal AML undergoing RFA from February 2002 to March 2010. • Patients underwent either laparoscopic or computed tomography (CT)‐guided percutaneous RFA using either the Cool‐tip™ (Covidien, Inc. Boulder, CO, USA) or RITA™ (Angiodynamics®, Latham, NY, USA) RFA probe. • CT at 1 month, 6 months, 1 year, and annually thereafter. RESULTS: • In all, two male and 13 female patients with seven left‐sided and eight right‐sided tumours with a mean (range) size of 2.6 (1.0–3.7) cm underwent laparoscopic (five) or CT‐guided (10) RFA. • No intraoperative complications occurred. Minor complications included transient haematuria and intercostals nerve transection. Surgical complications included pneumonia and myocardial infarction. • There was no radiographic evidence of persistent AML (CT enhancement) at a mean follow‐up of 21 months. CONCLUSIONS: • The haemostatic effect of RFA allows renal lesions suspicious for AML to be treated without bleeding complications. • Avoids surgical risk of extirpation or embolization. • RFA for renal AML is safe and effective.
- 1 October 2011
- Published by SAGE Publications in Videourology™
- Vol. 25 (5)
Simple Nephrectomy Using the TransEnterix SPIDER ® Surgical System
Introduction: The major drawback of laparoendoscopic single-site surgery (LESS) is the lack of triangulation with the use of rigid instruments. We introduce a video showing the University of Miami application of the TransEnterix SPIDER® (single-port instrument delivery extended reach) surgical system to facilitate single-port surgery in a case of a simple nephrectomy for an atrophic left kidney. The preparation of the device and the surgical steps are described in this video. Patient and Methods: One patient with a nonfunctioning kidney secondary to a ureteropelvic junction obstruction underwent a simple nephrectomy through a single incision performed using the SPIDER surgical system. We placed the SPIDER device via a GelPoint (Applied Medical, Rancho Santa Margarita, CA) and that was positioned through a 4-cm umbilical incision. For vision, we used a rigid 30-degree, 5-mm Karl Storz bariatric endoscope with a right-angled fiber optic light adaptor through one of the two rigid central ports of the SPIDER. We used the SPIDER flexible 5-mm Hem-o-lok clip (Teleflex Medical, Research Triangle Park, NC) appliers to ligate one of the arteries. One extra 12-mm port was placed through the GelPoint for an assistant laparoscopic grasper and 10-mm Hem-o-lok clip application on one of the two renal arteries and a 15-mm Hem-o-lok clip on the renal vein. Harmonic shears (Ethicon Endo-Surgery, Cincinnati, OH) were used through the 12-mm port only for the final step of dissection between the kidney and the adrenal gland through the assistant port. We made no additional skin incisions. The specimen was removed intact through the original incision. Results: The SPIDER-LESS nephrectomy was performed without additional skin incisions for laparoscopic ports, instrument clashing, or open conversion. Total operative time was 210 minutes, with blood loss of 50 mL. The patient experienced no intraoperative or postoperative complications. Pathology confirmed benign, atrophic renal parenchyma. Conclusions: The SPIDER surgical system LESS nephrectomy is feasible and safe. Studies of the next-generation technology are needed to further optimize its application in urology. Raymond J. Leveillee: Angiodynamics Inc., Scientific Study; Covidien Inc., Scientific Study/Consultant; Cook, Lecturer; Intuitive Surgical, Proctor; Applied Medical, Lecturer. All other authors: No competing financial interests exist. Runtime of video: 11 mins 39 secs
- 1 October 2011
- Published by SAGE Publications in Videourology™
- Vol. 25 (5)
Simple Nephrectomy Using the TransEnterix SPIDER ® Surgical System
Introduction: The major drawback of laparoendoscopic single-site surgery (LESS) is the lack of triangulation with the use of rigid instruments. We introduce a video showing the University of Miami application of the TransEnterix SPIDER® (single-port instrument delivery extended reach) surgical system to facilitate single-port surgery in a case of a simple nephrectomy for an atrophic left kidney. The preparation of the device and the surgical steps are described in this video. Patient and Methods: One patient with a nonfunctioning kidney secondary to a ureteropelvic junction obstruction underwent a simple nephrectomy through a single incision performed using the SPIDER surgical system. We placed the SPIDER device via a GelPoint (Applied Medical, Rancho Santa Margarita, CA) and that was positioned through a 4-cm umbilical incision. For vision, we used a rigid 30-degree, 5-mm Karl Storz bariatric endoscope with a right-angled fiber optic light adaptor through one of the two rigid central ports of the SPIDER. We used the SPIDER flexible 5-mm Hem-o-lok clip (Teleflex Medical, Research Triangle Park, NC) appliers to ligate one of the arteries. One extra 12-mm port was placed through the GelPoint for an assistant laparoscopic grasper and 10-mm Hem-o-lok clip application on one of the two renal arteries and a 15-mm Hem-o-lok clip on the renal vein. Harmonic shears (Ethicon Endo-Surgery, Cincinnati, OH) were used through the 12-mm port only for the final step of dissection between the kidney and the adrenal gland through the assistant port. We made no additional skin incisions. The specimen was removed intact through the original incision. Results: The SPIDER-LESS nephrectomy was performed without additional skin incisions for laparoscopic ports, instrument clashing, or open conversion. Total operative time was 210 minutes, with blood loss of 50 mL. The patient experienced no intraoperative or postoperative complications. Pathology confirmed benign, atrophic renal parenchyma. Conclusions: The SPIDER surgical system LESS nephrectomy is feasible and safe. Studies of the next-generation technology are needed to further optimize its application in urology. Raymond J. Leveillee: Angiodynamics Inc., Scientific Study; Covidien Inc., Scientific Study/Consultant; Cook, Lecturer; Intuitive Surgical, Proctor; Applied Medical, Lecturer. All other authors: No competing financial interests exist. Runtime of video: 11 mins 39 secs
- 21 July 2011
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 6 (2) , 155-157
Application of “cinch/tie” technique to robotic-assisted nephropexy for posterior abdominal wall fixation
Nephropexy remains standard for symptomatic nephroptosis, and several minimally-invasive techniques have been described. Triangulation sutures placed between the abdominal wall and the renal capsule are often difficult to tie tightly due to the confined working space. We propose a technique modification to fixate the kidney utilizing the da Vinci Surgical System robot and Lapra-Ty absorbable suture clips. Four female patients with symptomatic nephroptosis diagnosed via kidney hypermobility demonstrated on intravenous urography (IVU) underwent robotic-assisted laparoscopic nephropexy (RALNP) from February 2008 to April 2010. After complete mobilization and stripping of perirenal fat, several 0 Vicryl sutures were placed in a "figure of eight" fashion and tied loosely. Subsequently we utilized a Lapra-Ty to tighten the stitch serially and fixate the kidney. The mean age was 46 years (43-52); one patient underwent simultaneous pyeloplasty and one underwent partial nephrectomy in the ipsilateral kidney. There were no intraoperative complications and two postoperative complications, both Clavien grade I. All patients were asymptomatic postoperatively at a mean follow-up of 9.2 months (1-28), and had no evidence of kidney hypermobility on upright IVU or diuretic renal scintigraphy (RS) scan at 6 weeks postoperatively. RALNP is a viable option in the treatment of symptomatic nephroptosis. Secure placement of several "pexing" sutures helps to ensure appropriate security of these itinerant kidneys. Our technique modification corrects kidney hypermobility while improving symptoms related to nephroptosis.
- 21 July 2011
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 6 (2) , 155-157
Application of “cinch/tie” technique to robotic-assisted nephropexy for posterior abdominal wall fixation
Nephropexy remains standard for symptomatic nephroptosis, and several minimally-invasive techniques have been described. Triangulation sutures placed between the abdominal wall and the renal capsule are often difficult to tie tightly due to the confined working space. We propose a technique modification to fixate the kidney utilizing the da Vinci Surgical System robot and Lapra-Ty absorbable suture clips. Four female patients with symptomatic nephroptosis diagnosed via kidney hypermobility demonstrated on intravenous urography (IVU) underwent robotic-assisted laparoscopic nephropexy (RALNP) from February 2008 to April 2010. After complete mobilization and stripping of perirenal fat, several 0 Vicryl sutures were placed in a "figure of eight" fashion and tied loosely. Subsequently we utilized a Lapra-Ty to tighten the stitch serially and fixate the kidney. The mean age was 46 years (43-52); one patient underwent simultaneous pyeloplasty and one underwent partial nephrectomy in the ipsilateral kidney. There were no intraoperative complications and two postoperative complications, both Clavien grade I. All patients were asymptomatic postoperatively at a mean follow-up of 9.2 months (1-28), and had no evidence of kidney hypermobility on upright IVU or diuretic renal scintigraphy (RS) scan at 6 weeks postoperatively. RALNP is a viable option in the treatment of symptomatic nephroptosis. Secure placement of several "pexing" sutures helps to ensure appropriate security of these itinerant kidneys. Our technique modification corrects kidney hypermobility while improving symptoms related to nephroptosis.
- 1 July 2011
- Published by SAGE Publications in Journal of Endourology
- Vol. 25 (7) , 1119-1123
Improved Targeting of Radio-Frequency Ablation Probes and Thermal Sensors: A Preliminary Investigation of Flat-Panel CT-Guided Ablation of Renal Tumors Performed in the Cardiac Catheterization Laboratory
Flat-panel detector CT (FD-CT) provides cross-sectional CT-images while offering an improved workspace using fluoroscopic guidance for thermal probe placement such as for radiofrequency ablation (RFA) needles and thermal sensors. The purpose of this article is to test the feasibility of FD-CT in the application of renal tumor ablation in a "hybrid operating room" environment. Eleven patients with renal masses diagnosed preprocedurally with contrast-enhanced CT scan underwent core biopsy and simultaneous CT-RFA under general anesthesia with FD-CT guidance in the cardiac catheterization laboratory. Scans were taken preablation for tumor targeting, intermittently for probe placement and guidance of temperature sensors, and postablation. Perioperative and postoperative outcomes, pathologic results, and radiographic follow-up were recorded for each patient. Target temperatures >60°C to guide treatment end point were reached for each tumor periphery. Biopsy pathology showed 6/11 (55%) to be renal-cell carcinoma, and 2/11 (18%) to be benign; 3/11 (27%) had an indeterminate biopsy result. Three Clavien grade I complications occurred. One patient showed evidence of recurrent disease on postoperative CT scan. In our experience, we have found FD-CT-guided ablation of small renal tumors to be feasible using this advanced targeting system.
- 1 July 2011
- Published by SAGE Publications in Journal of Endourology
- Vol. 25 (7) , 1119-1123
Improved Targeting of Radio-Frequency Ablation Probes and Thermal Sensors: A Preliminary Investigation of Flat-Panel CT-Guided Ablation of Renal Tumors Performed in the Cardiac Catheterization Laboratory
Flat-panel detector CT (FD-CT) provides cross-sectional CT-images while offering an improved workspace using fluoroscopic guidance for thermal probe placement such as for radiofrequency ablation (RFA) needles and thermal sensors. The purpose of this article is to test the feasibility of FD-CT in the application of renal tumor ablation in a "hybrid operating room" environment. Eleven patients with renal masses diagnosed preprocedurally with contrast-enhanced CT scan underwent core biopsy and simultaneous CT-RFA under general anesthesia with FD-CT guidance in the cardiac catheterization laboratory. Scans were taken preablation for tumor targeting, intermittently for probe placement and guidance of temperature sensors, and postablation. Perioperative and postoperative outcomes, pathologic results, and radiographic follow-up were recorded for each patient. Target temperatures >60°C to guide treatment end point were reached for each tumor periphery. Biopsy pathology showed 6/11 (55%) to be renal-cell carcinoma, and 2/11 (18%) to be benign; 3/11 (27%) had an indeterminate biopsy result. Three Clavien grade I complications occurred. One patient showed evidence of recurrent disease on postoperative CT scan. In our experience, we have found FD-CT-guided ablation of small renal tumors to be feasible using this advanced targeting system.
- 1 June 2011
- Published by SAGE Publications in Journal of Endourology
- Vol. 25 (6) , 923-925
Initial Experience with Laparoendoscopic Single-Site Simple Nephrectomy Using the TransEnterix SPIDER Surgical System: Assessing Feasibility and Safety
Purpose: The goal of this report is to describe our initial clinical experience performing a simple nephrectomy with the SPIDER (Single Port Instrument Delivery Extended Reach) laparoendoscopic single-site (LESS) surgical system. Patient and Methods: One patient with a nonfunctioning kidney secondary to a ureteropelvic junction obstruction underwent a simple nephrectomy through a single incision performed using the SPIDER surgical system. We assessed the technical feasibility, efficiency, and perioperative outcomes. Results: The SPIDER-LESS nephrectomy was performed successfully without additional skin incisions for laparoscopic ports, instrument clashing, or open conversion. Total operative time was 210 minutes with blood loss of 50 mL. The patient experienced no intraoperative or postoperative complications. Pathologic evaluation confirmed atrophic renal parenchyma. Conclusions: The SPIDER surgical system LESS nephrectomy is feasible and safe. Future refinements of the technology and prospective studies are needed to further optimize its application in urology.
- 1 June 2011
- Published by SAGE Publications in Journal of Endourology
- Vol. 25 (6) , 923-925
Initial Experience with Laparoendoscopic Single-Site Simple Nephrectomy Using the TransEnterix SPIDER Surgical System: Assessing Feasibility and Safety
Purpose: The goal of this report is to describe our initial clinical experience performing a simple nephrectomy with the SPIDER (Single Port Instrument Delivery Extended Reach) laparoendoscopic single-site (LESS) surgical system. Patient and Methods: One patient with a nonfunctioning kidney secondary to a ureteropelvic junction obstruction underwent a simple nephrectomy through a single incision performed using the SPIDER surgical system. We assessed the technical feasibility, efficiency, and perioperative outcomes. Results: The SPIDER-LESS nephrectomy was performed successfully without additional skin incisions for laparoscopic ports, instrument clashing, or open conversion. Total operative time was 210 minutes with blood loss of 50 mL. The patient experienced no intraoperative or postoperative complications. Pathologic evaluation confirmed atrophic renal parenchyma. Conclusions: The SPIDER surgical system LESS nephrectomy is feasible and safe. Future refinements of the technology and prospective studies are needed to further optimize its application in urology.